{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:52:17Z","timestamp":1768405937611,"version":"3.49.0"},"reference-count":12,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Conventional ophthalmic formulations lack a prolonged drug release effect and mucoadhesive properties, decreasing their residence time in the precorneal area and, therefore, in drug penetration across ocular tissues, presenting low bioavailability with a consequent reduction in therapeutic efficacy [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics15061675","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:34:32Z","timestamp":1686188072000},"page":"1675","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nanoparticles in Ocular Drug Delivery Systems"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0799-2335","authenticated-orcid":false,"given":"Hugo","family":"Almeida","sequence":"first","affiliation":[{"name":"UCIBIO (Research Unit on Applied Molecular Biosciences), REQUIMTE (Rede de Qu\u00edmica e Tecnologia), MEDTECH (Medicines and Healthcare Products), Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"Mesosystem Investiga\u00e7\u00e3o & Investimentos by Spinpark, Barco, 4805-017 Guimar\u00e3es, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-0232","authenticated-orcid":false,"given":"Ana Catarina","family":"Silva","sequence":"additional","affiliation":[{"name":"UCIBIO (Research Unit on Applied Molecular Biosciences), REQUIMTE (Rede de Qu\u00edmica e Tecnologia), MEDTECH (Medicines and Healthcare Products), Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"FP-BHS (Biomedical and Health Sciences Research Unit), FP-I3ID (Instituto de Investiga\u00e7\u00e3o, Inova\u00e7\u00e3o e Desenvolvimento), Faculty of Health Sciences, University Fernando Pessoa, 4249-004 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Formica, M.L., Awde Alfonso, H.G., Paredes, A.J., Melian, M.E., Camacho, N.M., Faccio, R., T\u00e1rtara, L.I., and Palma, S.D. (2023). Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020683"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rawat, P.S., Ravi, P.R., Mir, S.I., Khan, M.S., Kathuria, H., Katnapally, P., and Bhatnagar, U. (2023). Design, Characterization and Pharmacokinetic\u2013Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020405"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Senapati, S., Youssef, A.A.A., Sweeney, C., Cai, C., Dudhipala, N., and Majumdar, S. (2022). Cannabidiol Loaded Topical Ophthalmic Nanoemulsion Lowers Intraocular Pressure in Normotensive Dutch-Belted Rabbits. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122585"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Aziz, D., Mohamed, S.A., Tayel, S., and Makhlouf, A. (2022). Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081746"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"De Clerck, K., Accou, G., Sauvage, F., Braeckmans, K., De Smedt, S.C., Remaut, K., and Peynshaert, K. (2022). Photodisruption of the Inner Limiting Membrane: Exploring ICG Loaded Nanoparticles as Photosensitizers. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081716"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Uwaezuoke, O., Du Toit, L.C., Kumar, P., Ally, N., and Choonara, Y.E. (2022). Linoleic Acid-Based Transferosomes for Topical Ocular Delivery of Cyclosporine A. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081695"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jacinto, T.A., Oliveira, B., Miguel, S.P., Ribeiro, M.P., and Coutinho, P. (2022). Ciprofloxacin-Loaded Zein\/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081557"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hnin, H.M., Stef\u00e1nsson, E., Loftsson, T., Asasutjarit, R., Charnvanich, D., and Jansook, P. (2022). Physicochemical and Stability Evaluation of Topical Niosomal Encapsulating Fosinopril\/\u03b3-Cyclodextrin Complex for Ocular Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061147"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Albarqi, H.A., Garg, A., Ahmad, M.Z., Alqahtani, A.A., Walbi, I.A., and Ahmad, J. (2023). Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020681"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shastri, D.H., Silva, A.C., and Almeida, H. (2023). Ocular Delivery of Therapeutic Proteins: A Review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010205"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Orash Mahmoud Salehi, A., Heidari-Keshel, S., Poursamar, S.A., Zarrabi, A., Sefat, F., Mamidi, N., Behrouz, M.J., and Rafienia, M. (2022). Bioprinted Membranes for Corneal Tissue Engineering: A Review. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122797"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zingale, E., Romeo, A., Rizzo, S., Cimino, C., Bonaccorso, A., Carbone, C., Musumeci, T., and Pignatello, R. (2022). Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050955"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/6\/1675\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:50:27Z","timestamp":1760125827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/6\/1675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["pharmaceutics15061675"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15061675","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}